Free Trial

Aligos Therapeutics (ALGS) Earnings Date, Estimates & Call Transcripts

$0.67
+0.03 (+4.40%)
(As of 01:22 PM ET)

Earnings Summary

Upcoming
Earnings Date
Aug. 1Estimated
Actual EPS
(Mar. 12)
-$0.22 Beat By $0.05
Consensus EPS
(Mar. 12)
-$0.27
Skip Charts & View Estimated and Actual Earnings Data

ALGS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ALGS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Aligos Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241($0.19)($0.19)($0.19)
Q2 20241($0.16)($0.16)($0.16)
Q3 20241($0.17)($0.17)($0.17)
Q4 20241($0.19)($0.19)($0.19)
FY 20244($0.71)($0.71)($0.71)

ALGS Earnings Date and Information

Aligos Therapeutics last released its quarterly earnings data on March 12th, 2024. The reported ($0.22) EPS for the quarter, beating analysts' consensus estimates of ($0.27) by $0.05. The business earned $2.68 million during the quarter, compared to analyst estimates of $3.20 million. Aligos Therapeutics has generated ($1.28) earnings per share over the last year (($1.28) diluted earnings per share). Earnings for Aligos Therapeutics are expected to grow in the coming year, from ($0.74) to ($0.63) per share. Aligos Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off prior year's report dates.

Aligos Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/1/2024
(Estimated)
------- 
3/12/2024Q4 2023($0.27)($0.22)+$0.05($0.22)$3.20 million$2.68 million
11/2/2023Q3 2023($0.48)($0.41)+$0.07($0.41)$5.00 million$2.15 million
8/3/2023Q2 2023($0.50)($0.43)+$0.07($0.43)-$6.89 million
5/4/2023Q1 2023($0.49)($0.53)($0.04)($0.53)$4.30 million$2.72 million
3/9/2023Q4 2022($0.49)($0.51)($0.02)($0.51)$2.80 million$3.54 million
11/2/2022Q3 2022($0.57)($0.44)+$0.13($0.44)-$4.11 million
8/4/2022Q2 2022($0.65)($0.47)+$0.18($0.47)-$3.69 million
5/4/2022Q1 2022($0.66)($0.84)($0.18)($0.84)-$2.57 million    
3/10/2022Q4 2021($0.83)($0.89)($0.06)($0.89)-$0.37 million
11/3/2021Q3 2021($0.81)($0.78)+$0.03($0.78)-$1.54 million
8/4/2021Q2 2021($0.81)($0.79)+$0.02($0.79)-$1.55 million
5/9/2021Q1 2021($0.90)($0.74)+$0.16($0.74)-$0.91 million
3/22/2021Q4($0.8250)($1.09)($0.2650)($1.09)--

Aligos Therapeutics Earnings - Frequently Asked Questions

When is Aligos Therapeutics's earnings date?

Aligos Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, August 1st, 2024 based off last year's report dates. Learn more on ALGS's earnings history.

Did Aligos Therapeutics beat their earnings estimates last quarter?

In the previous quarter, Aligos Therapeutics (NASDAQ:ALGS) reported ($0.22) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.05. Learn more on analysts' earnings estimate vs. ALGS's actual earnings.

How much revenue does Aligos Therapeutics generate each year?

Aligos Therapeutics (NASDAQ:ALGS) has a recorded annual revenue of $15.53 million.

How much profit does Aligos Therapeutics generate each year?

Aligos Therapeutics (NASDAQ:ALGS) has a recorded net income of -$87.68 million. ALGS has generated -$1.28 earnings per share over the last four quarters.

What is Aligos Therapeutics's EPS forecast for next year?

Aligos Therapeutics's earnings are expected to grow from ($0.74) per share to ($0.63) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:ALGS) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners